Corticosteroid therapy for hearing and balance disorders - Wikidata - awgldk - TriplyDB

Corticosteroid therapy for hearing and balance disorders

Corticosteroid therapy for hearing and balance disorders

http://www.wikidata.org/entity/Q30439597

about

Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss Intracochlear drug delivery in combination with cochlear implants : Current aspects [Intracochlear drug delivery in combination with cochlear implants : Current aspects].A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection.Electroacoustic stimulation: now and into the future Intratympanic Steroid Treatments May Improve Hearing via Ion Homeostasis Alterations and Not Immune Suppression Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A.Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss Early investigational drugs for hearing loss.Control of middle ear inflammatory and ion homeostasis genes by transtympanic glucocorticoid and mineralocorticoid treatments.Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media.Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs.The effect of intra-tympanic dexamethasone on the vestibular function in patients with recurrent vertigo.Symptomatic sensorineural hearing loss in patients with ulcerative colitis.Continuous topical drug delivery using osmotic pump in animal cochlear implant model: Continuous steroid delivery is effective for hearing preservation.Evaluation of a transtympanic delivery system in Mus musculus for extended release steroids.Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone: A Randomized Controlled Study.Diagnostics and therapy of sudden hearing loss.Intratympanic corticosteroids in Ménière's disease: A mini-review.Auditory disorders and future therapies with delivery systems

P2860

Q28388403-66BDF5C8-320E-48F8-B9E7-A603063AC42F Q30313632-4B80EC8D-55FC-469E-8B04-FD087FA266D7 Q30313814-C2BF7311-C646-4D88-81D8-844170235342 Q30356606-5CC3B3C2-D175-4010-AEAD-2E532B2F0CEC Q30367376-02305481-0A25-4006-90D7-09616145B352 Q30380467-6C8F641D-837A-4EE4-84AE-C09D9CC88CBA Q30382813-481F89E0-B0E3-48F8-9EC7-566568BD4BC2 Q30383830-45080483-0B97-4D0F-B0D3-0FF4469188FB Q30392675-86F34AF3-6EF3-4BCD-BA59-BFBDFC5980D5 Q30411180-8AD57A69-D380-473C-9E11-00701EB906C0 Q30430796-C261E3C7-694B-4C19-A318-7F8571A890C0 Q33847686-87C506B0-7E6D-445B-AF71-75BDD2B4DFA3 Q35587454-530CA68E-29F4-4BA1-931B-924A6C37A0D8 Q35822607-E29587F9-047C-4C85-965D-A61142518086 Q38547824-B919B81A-CD08-4030-AB3F-B5F492A9DD1C Q38561410-9367C389-AB57-4DD4-8603-A8862E328137 Q41476541-9EE00411-00ED-4E04-8DF3-64741E167678 Q46830952-42273C2E-53CF-48E4-BE46-BA81C6EBBDE8 Q50061307-2BE2923F-8F0D-4F8D-A933-0ADA7C12377C Q50425895-0091D7F9-CDC5-4979-8748-2BBE621218EF Q52808579-4407C4F2-2DA2-4171-96B1-06646698CE5A Q55256387-5014ADF1-BB09-4E36-9EAF-D2A629F7C715 Q58593680-2D4DE55E-2080-4D9A-887F-3A1E632044AD

P2860

Corticosteroid therapy for hearing and balance disorders

http://www.wikidata.org/entity/Q30439597

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Corticosteroid therapy for hearing and balance disorders

@ast

Corticosteroid therapy for hearing and balance disorders

@en

type

label

Corticosteroid therapy for hearing and balance disorders

@ast

Corticosteroid therapy for hearing and balance disorders

@en

prefLabel

Corticosteroid therapy for hearing and balance disorders

@ast

Corticosteroid therapy for hearing and balance disorders

@en

P1433

Q30439597-9913C47D-C497-4C91-B2D4-663711F4DF81

P1476

Q30439597-EC9CC7CE-5E70-476A-953B-13A89169B714

P2093

Q30439597-24A284F8-DEE0-4082-801D-328B4DFD4A92

Q30439597-8FA502BD-5A53-45CA-A263-BDB283D50340

P2860

Q30439597-01C514B9-C403-4D93-AC18-75C0BE50FAF3

Q30439597-01EE7EE8-0684-44A4-9DC0-4495E41EF80B

Q30439597-024A017D-F60B-4779-88A4-59DFC8C9A31B

Q30439597-027553B8-C621-4264-A00D-43735C8761D6

Q30439597-0414EAB3-3F8A-42A8-B50F-98096C5FEAEF

Q30439597-04693583-22CB-43F8-9007-26B66DBBE979

Q30439597-063B415B-E05C-4CCC-89E8-C4561B8E901E

Q30439597-0867E326-56D1-4B5C-ADAD-58BBC8A3FE4C

Q30439597-094BC84F-D09A-4B8C-B73B-D65D88A4FDCA

Q30439597-0A444C10-E1A7-4649-87E3-FE14C1A6050F

P304

Q30439597-17D24F89-9502-4F93-AA3F-C048987B4495

P31

Q30439597-75AF9211-E4AC-49C2-8DEF-AA29FBBDA202

P356

Q30439597-83DF0FE9-9A54-410F-99C0-4CEB00771AE9

P433

Q30439597-86FDCBDA-6347-4E4E-AA14-BF77630F7309

P478

Q30439597-FA83298B-99BD-4EC4-8821-C08D0D4C6B79

P577

Q30439597-5CDC7052-1D99-44ED-A3CC-F9458D45E42D

P5875

Q30439597-362D4CE9-0243-42B1-8571-F0C232A249BA

P698

Q30439597-D7D0D6DB-6388-4DA7-A164-8710E08AD6A3

P932

Q30439597-B1AE5B03-8E72-4149-8E29-D5DE742C03A9

P356

P1433

The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology

P1476

Corticosteroid therapy for hearing and balance disorders

@en

P2093

Barbara Canlon

http://www.w3.org/2001/XMLSchema#string

Dennis R Trune

http://www.w3.org/2001/XMLSchema#string

P2860

Intratympanic steroids for Ménière's disease or syndrome

Steroids for idiopathic sudden sensorineural hearing loss

Diuretics for Ménière's disease or syndrome

Autoimmunity in sudden sensorineural hearing loss: possible role of anti-endothelial cell autoantibodies

Sound conditioning protects hearing by activating the hypothalamic–pituitary–adrenal axis

Progestin negatively affects hearing in aged women.

IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.

Low dose combination steroids control autoimmune mouse hearing loss.

Ion homeostasis in the ear: mechanisms, maladies, and management.

Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial.

P304

1928-1943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AR.22576

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

295

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232223191

http://www.w3.org/2001/XMLSchema#string

P698

23044978

http://www.w3.org/2001/XMLSchema#string

P932

3999710

http://www.w3.org/2001/XMLSchema#string